Ro
Healthcare
Founded: 2017
Last Round Valuation: $7.19B
Ro, headquartered in New York, NY, is a telehealth platform that offers a wide range of healthcare services and personalized treatment options. Their platform caters to various concerns, including erectile dysfunction, fertility, hair, and skin issues. Users can conveniently access medication delivery through the Ro platform. The company was founded in 2017 by Zachariah Reitano, Saman Rahmanian, and Robert Schutz. By leveraging telehealth technology, Ro aims to make healthcare more accessible and convenient for individuals seeking treatment for their specific health needs. Through their digital platform, Ro provides a seamless experience for users to connect with healthcare professionals and receive personalized care from the comfort of their own homes.
Ro Overview:
Ro, founded in 2017 by Zachariah Reitano, Saman Rahmanian, and Robert Schutz, is a prominent telehealth platform headquartered in New York, NY. The company's mission is to provide accessible and personalized healthcare solutions for a range of concerns, including erectile dysfunction, fertility, hair loss, and skin issues.
At the core of Ro's services is their telehealth platform, which enables individuals to connect with healthcare professionals remotely. Through this platform, users can discreetly and conveniently seek medical advice, obtain personalized treatment options, and receive necessary prescriptions without the need for in-person appointments.
Ro's approach to healthcare involves leveraging technology to break down barriers to access, allowing individuals to address sensitive health concerns with ease and privacy. By providing a user-friendly digital interface, Ro streamlines the process of receiving care, eliminating the traditional obstacles associated with scheduling appointments, traveling to clinics, and waiting in crowded waiting rooms.
One of the key areas Ro focuses on is the treatment of erectile dysfunction (ED). By offering a comprehensive telemedicine solution, Ro provides discreet consultations with licensed healthcare professionals who can diagnose and prescribe appropriate medication for ED. In addition, Ro offers medication delivery services, ensuring that individuals have convenient access to the prescribed treatments.
Ro also addresses fertility concerns through their telehealth platform. They provide consultations and personalized treatment options for couples and individuals seeking fertility support. By connecting patients with fertility specialists, Ro helps guide them through the journey of fertility evaluation, diagnosis, and treatment, offering personalized care and support along the way.
In addition to ED and fertility, Ro addresses hair loss and skin issues through their platform. They offer virtual consultations with healthcare professionals who can recommend appropriate treatments and provide prescriptions as needed. Ro's holistic approach to healthcare encompasses providing comprehensive solutions for individuals seeking to address these specific concerns.
Ro's commitment to patient care and safety is evident in their rigorous vetting process for healthcare professionals on their platform. All healthcare providers go through a thorough review and credentialing process to ensure high-quality care and adherence to industry standards.
Since its inception, Ro has experienced significant growth and has expanded its services to meet the evolving needs of its users. They continue to innovate in the telehealth space, leveraging technology to deliver accessible, personalized, and convenient healthcare solutions. Through their platform, Ro aims to empower individuals to take control of their health and well-being, providing them with the support they need to live healthier lives.
Founders:
Zachariah Reitano
Saman Rahmanian
Robert Schutz
Top Investors:
3LAltimeter Capital
Baupost Group
Blue 9 Capital
BoxGroup
Canaan Partners
Chapter One Ventures
Dragoneer
Evolution VC Partners
FirstMark Capital
General Catalys
Initialized Capital Management
J Ventures
PROOF Fund
Radcliff
Rosecliff Venture Partners
Sand Hill Angels
Seven Seven Six
ShawSpring Partners
SignalFire
Sinai Ventures
Slow Ventures
TQ Ventures
The Chernin Group
Torch Capital
Tusk Ventures
Funding History:
Date | Share Type | Amount Raised | Raised to Date | Issue Price | Post Money Valuation | Key Investors |
---|---|---|---|---|---|---|
Feb 2022 | Series D-1 | $100MM | $884.86MM | $15.33 | $7.19B | ShawSpring Partners, General Catalyst, FirstMark Capital |
Mar 2021 | Series D | $510MM | $784.86MM | $11.89 | $5.25B | General Catalyst, FirstMark Capital and TQ Ventures, SignalFire |
Jul 2020 | Series C-3 | $40.6MM | $192.92MM | $3.26 | $1.8B | General Catalyst, FirstMark Capital, Torch |
Jul 2020 | Series C-2 | $39.79MM | $192.11MM | $3.26 | $1.8B | General Catalyst, FirstMark Capital, Torch |
Jul 2020 | Series C-1 | $42.15MM | $194.48MM | $4.08 | $1.8B | General Catalyst, FirstMark Capital, Torch |
Jul 2020 | Series B | $85.54MM | $152.32MM | $1.49 | $540.95MM | FirstMark Capital, PROOF Fund, Canaan Partners |
Sep 2019 | Series A | $19.95MM | $23.1MM | $0.45 | $240.27MM | FirstMark Capital, General Catalyst, Rosecliff Venture Partners |
Sep 2019 | Series A-1 | $3.69MM | $6.84MM | $0.36 | $240.27MM | FirstMark Capital, General Catalyst, Rosecliff Venture Partners |
Sep 2019 | Series A-2 | $39.99MM | $43.14MM | $0.79 | $240.27MM | FirstMark Capital, General Catalyst, Rosecliff Venture Partners |
Aug 2017 | Series Seed | $3.15MM | $3.15MM | $0.10 | $19.84MM | General Catalyst |